Answers are grounded in this paper and cite their sources.
As the Medical Education Editor for Respirology, I enjoy the opportunity to highlight novel papers in each edition of the journal. In the third quarter of 2026, I was fortunate to select papers ranging from very common presentations (infective exacerbations of chronic obstructive pulmonary disease (COPD)) to much rarer ones (outcomes after pulmonary endarterectomy (PEA) and survival in checkpoint inhibitor pneumonitis (CIP)): C. Wong, Y. W. Lam, V. N. Yew, et al., “Real-World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbations,” https://doi.org/10.1002/resp.70242. C. C. Chan, B. L. Teixeira, A. Bautista, et al., “Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension,” https://doi.org/10.1002/resp.70255. T. Hirakawa, K. Yamaguchi, S. Takao, et al., “Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation,” https://doi.org/10.1002/resp.70267.
No takes yet. Share an insight, caveat, or question.
Mark Lavercombe (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: